Loading...
Header Logo
Keywords
Last Name
Institution

Roger G Harrison

TitleProfessor
InstitutionUniversity of Oklahoma, Norman
DepartmentChemical, Biological and Materials Engineering
Address100 Boyd St
Norman OK
Phone(405) 325-4367
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Guillen KP, Ruben EA, Virani N, Harrison RG. Annexin-directed ß-glucuronidase for the targeted treatment of solid tumors. Protein Eng Des Sel. 2017 Feb; 30(2):85-94. PMID: 27986920.
      View in: PubMed
    2. Guillen KP, Restuccia A, Kurkjian C, Harrison RG. Annexin V-Directed Enzyme Prodrug Therapy Plus Docetaxel for the Targeted Treatment of Pancreatic Cancer. Pancreas. 2015 Aug; 44(6):945-52. PMID: 25899647.
      View in: PubMed
    3. Harrison RG, Bagajewicz MJ. Predicting the solubility of recombinant proteins in Escherichia coli. Methods Mol Biol. 2015; 1258:403-8. PMID: 25447878.
      View in: PubMed
    4. Krais JJ, De Crescenzo O, Harrison RG. Purine nucleoside phosphorylase targeted by annexin v to breast cancer vasculature for enzyme prodrug therapy. PLoS One. 2013; 8(10):e76403. PMID: 24098491; PMCID: PMC3789731.
    5. Van Rite BD, Krais JJ, Cherry M, Sikavitsas VI, Kurkjian C, Harrison RG. Antitumor activity of an enzyme prodrug therapy targeted to the breast tumor vasculature. Cancer Invest. 2013 Oct; 31(8):505-10. PMID: 24083814.
      View in: PubMed
    6. Neves LF, Krais JJ, Van Rite BD, Ramesh R, Resasco DE, Harrison RG. Targeting single-walled carbon nanotubes for the treatment of breast cancer using photothermal therapy. Nanotechnology. 2013 Sep 20; 24(37):375104. PMID: 23975064.
      View in: PubMed
    7. Prickett WM, Van Rite BD, Resasco DE, Harrison RG. Vascular targeted single-walled carbon nanotubes for near-infrared light therapy of cancer. Nanotechnology. 2011 Nov 11; 22(45):455101. PMID: 21993223.
      View in: PubMed
    8. Van Rite BD, Harrison RG. Annexin V-targeted enzyme prodrug therapy using cytosine deaminase in combination with 5-fluorocytosine. Cancer Lett. 2011 Aug 01; 307(1):53-61. PMID: 21546157.
      View in: PubMed
    9. Van Rite BD, Lazrak YA, Pagnon ML, Palwai NR, Neves LF, McFetridge PS, Harrison RG. Enzyme prodrug therapy designed to target L-methioninase to the tumor vasculature. Cancer Lett. 2011 Feb 28; 301(2):177-84. PMID: 21194833.
      View in: PubMed
    10. Diaz AA, Tomba E, Lennarson R, Richard R, Bagajewicz MJ, Harrison RG. Prediction of protein solubility in Escherichia coli using logistic regression. Biotechnol Bioeng. 2010 Feb 01; 105(2):374-83. PMID: 19739095.
      View in: PubMed
    11. Neves LF, Tsai TW, Palwai NR, Martyn DE, Tan Y, Schmidtke DW, Resasco DE, Harrison RG. Non-covalent attachment of proteins to single-walled carbon nanotubes. Methods Mol Biol. 2010; 625:3-8. PMID: 20422376.
      View in: PubMed
    12. Tsai TW, Heckert G, Neves LF, Tan Y, Kao DY, Harrison RG, Resasco DE, Schmidtke DW. Adsorption of glucose oxidase onto single-walled carbon nanotubes and its application in layer-by-layer biosensors. Anal Chem. 2009 Oct 01; 81(19):7917-25. PMID: 19788314.
      View in: PubMed
    13. Palwai NR, Zang XP, Harrison RG, Benbrook D, Pento JT. Selective growth inhibition of cancer cells by L-methioninase-containing fusion protein targeted to the urokinase receptor. Pharmacology. 2009; 84(5):271-5. PMID: 19797936; PMCID: PMC2834258.
    14. Palwai NR, Zang XP, Harrison RG, Pento JT. Influence of L-methioninase targeted to the urokinase receptor on the proliferation and motility of lung and prostate cancer cells. Anticancer Res. 2007 Sep-Oct; 27(5A):3435-9. PMID: 17970092.
      View in: PubMed
    15. Peron K, Jones TN, Gauthier SA, Nguyen TN, Zang XP, Barriere M, Prévéraud D, Soliman CE, Harrison RG, Pento JT. Targeting of a novel fusion protein containing methioninase to the urokinase receptor to inhibit breast cancer cell migration and proliferation. Cancer Chemother Pharmacol. 2003 Oct; 52(4):270-6. PMID: 12827296.
      View in: PubMed
    16. Davis GD, Harrison RG. Discovery of new fusion protein systems designed to enhance solubility in E. coli. Methods Mol Biol. 2003; 205:141-54. PMID: 12491884.
      View in: PubMed
    Harrison's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _